{"status":"ok","message-type":"work","message-version":"1.0.0","message":{"indexed":{"date-parts":[[2026,7,17]],"date-time":"2026-07-17T17:13:36Z","timestamp":1784308416072,"version":"3.55.0"},"reference-count":40,"publisher":"Impact Journals, LLC","issue":"19","content-domain":{"domain":[],"crossmark-restriction":false},"short-container-title":["Oncotarget"],"published-print":{"date-parts":[[2015,7,10]]},"DOI":"10.18632\/oncotarget.3746","type":"journal-article","created":{"date-parts":[[2015,9,15]],"date-time":"2015-09-15T06:30:15Z","timestamp":1442298615000},"page":"17261-17275","source":"Crossref","is-referenced-by-count":43,"title":["Peritoneal tumor spread in serous ovarian cancer-epithelial mesenchymal status and outcome"],"prefix":"10.18632","volume":"6","author":[{"given":"Katharina","family":"Auer","sequence":"first","affiliation":[{"name":"Department of Obstetrics and Gynecology, Comprehensive Cancer Center (CCC), Medical University of Vienna and Ludwig Boltzmann Cluster Translational Oncology, Vienna, Austria"}],"role":[{"vocabulary":"crossref","role":"author"}]},{"given":"Anna","family":"Bachmayr-Heyda","sequence":"additional","affiliation":[{"name":"Department of Obstetrics and Gynecology, Comprehensive Cancer Center (CCC), Medical University of Vienna and Ludwig Boltzmann Cluster Translational Oncology, Vienna, Austria"}],"role":[{"vocabulary":"crossref","role":"author"}]},{"given":"Stefanie","family":"Aust","sequence":"additional","affiliation":[{"name":"Department of Obstetrics and Gynecology, Comprehensive Cancer Center (CCC), Medical University of Vienna and Ludwig Boltzmann Cluster Translational Oncology, Vienna, Austria"}],"role":[{"vocabulary":"crossref","role":"author"}]},{"given":"Nyamdelger","family":"Sukhbaatar","sequence":"additional","affiliation":[{"name":"Department of Obstetrics and Gynecology, Comprehensive Cancer Center (CCC), Medical University of Vienna and Ludwig Boltzmann Cluster Translational Oncology, Vienna, Austria"}],"role":[{"vocabulary":"crossref","role":"author"}]},{"given":"Agnes Teresa","family":"Reiner","sequence":"additional","affiliation":[{"name":"Department of Obstetrics and Gynecology, Comprehensive Cancer Center (CCC), Medical University of Vienna and Ludwig Boltzmann Cluster Translational Oncology, Vienna, Austria"}],"role":[{"vocabulary":"crossref","role":"author"}]},{"given":"Christoph","family":"Grimm","sequence":"additional","affiliation":[{"name":"Department of Obstetrics and Gynecology, Comprehensive Cancer Center (CCC), Medical University of Vienna and Ludwig Boltzmann Cluster Translational Oncology, Vienna, Austria"}],"role":[{"vocabulary":"crossref","role":"author"}]},{"given":"Reinhard","family":"Horvat","sequence":"additional","affiliation":[{"name":"Department of Pathology, Medical University of Vienna, Vienna, Austria"}],"role":[{"vocabulary":"crossref","role":"author"}]},{"given":"Robert","family":"Zeillinger","sequence":"additional","affiliation":[{"name":"Department of Obstetrics and Gynecology, Comprehensive Cancer Center (CCC), Medical University of Vienna and Ludwig Boltzmann Cluster Translational Oncology, Vienna, Austria"}],"role":[{"vocabulary":"crossref","role":"author"}]},{"given":"Dietmar","family":"Pils","sequence":"additional","affiliation":[{"name":"Department of Obstetrics and Gynecology, Comprehensive Cancer Center (CCC), Medical University of Vienna and Ludwig Boltzmann Cluster Translational Oncology, Vienna, Austria"}],"role":[{"vocabulary":"crossref","role":"author"}]}],"member":"7892","published-online":{"date-parts":[[2015,5,11]]},"reference":[{"key":"1","doi-asserted-by":"crossref","first-page":"69","DOI":"10.3322\/caac.20107","article-title":"Global cancer statistics","volume":"61","author":"Forman","year":"2011","journal-title":"CA Cancer J Clin"},{"key":"2","doi-asserted-by":"crossref","first-page":"505","DOI":"10.1016\/S0140-6736(02)09738-6","article-title":"Paclitaxel plus carboplatin versus standard chemotherapy with either single-agent carboplatin or cyclophosphamide, doxorubicin, and cisplatin in women with ovarian cancer: the ICON3 randomised trial","volume":"360","author":"International Collaborative Ovarian Neoplasm G","year":"2002","journal-title":"Lancet"},{"key":"3","doi-asserted-by":"crossref","first-page":"194","DOI":"10.1038\/nrclinonc.2012.28","article-title":"Gynecological cancer: First-line bevacizumab for ovarian cancer-new standard of care?","volume":"9","author":"Kaye","year":"2012","journal-title":"Nature reviews Clinical oncology"},{"key":"4","doi-asserted-by":"crossref","first-page":"747","DOI":"10.1038\/35021093","article-title":"Molecular portraits of human breast tumours","volume":"406","author":"Borresen-Dale","year":"2000","journal-title":"Nature"},{"key":"5","doi-asserted-by":"crossref","first-page":"5222","DOI":"10.1158\/1078-0432.CCR-10-1282","article-title":"A comparison of PAM50 intrinsic subtyping with immunohistochemistry and clinical prognostic factors in tamoxifen-treated estrogen receptor-positive breast cancer","volume":"16","author":"Ellis","year":"2010","journal-title":"Clinical cancer research : an official journal of the American Association for Cancer Research"},{"key":"6","doi-asserted-by":"crossref","first-page":"8171","DOI":"10.1038\/sj.onc.1207979","article-title":"Gene expression profiling of advanced ovarian cancer: characterization of a molecular signature involving fibroblast growth factor 2","volume":"23","author":"Raspagliesi","year":"2004","journal-title":"Oncogene"},{"key":"7","doi-asserted-by":"crossref","first-page":"5198","DOI":"10.1158\/1078-0432.CCR-08-0196","article-title":"Novel molecular subtypes of serous and endometrioid ovarian cancer linked to clinical outcome","volume":"14","author":"Haviv","year":"2008","journal-title":"Clin Cancer Res"},{"key":"8","doi-asserted-by":"crossref","first-page":"1421","DOI":"10.1111\/j.1349-7006.2009.01204.x","article-title":"Gene expression profiling of advanced-stage serous ovarian cancers distinguishes novel subclasses and implicates ZEB2 in tumor progression and prognosis","volume":"100","author":"Tanaka","year":"2009","journal-title":"Cancer Sci"},{"key":"9","doi-asserted-by":"crossref","first-page":"609","DOI":"10.1038\/nature10166","article-title":"Integrated genomic analyses of ovarian carcinoma","volume":"474","author":"Cancer Genome Atlas Research N","year":"2011","journal-title":"Nature"},{"key":"10","doi-asserted-by":"crossref","first-page":"1334","DOI":"10.1111\/j.1349-7006.2012.02306.x","article-title":"Validating the impact of a molecular subtype in ovarian cancer on outcomes: a study of the OVCAD Consortium","volume":"103","author":"Zeillinger","year":"2012","journal-title":"Cancer Sci"},{"key":"11","doi-asserted-by":"crossref","first-page":"273","DOI":"10.1038\/nrc3432","article-title":"Meeting the challenge of ascites in ovarian cancer: new avenues for therapy and research","volume":"13","author":"Kaye","year":"2013","journal-title":"Nature reviews Cancer"},{"key":"12","first-page":"3584","article-title":"Mechanisms of human tumor metastasis studied in patients with peritoneovenous shunts","volume":"44","author":"Crossley","year":"1984","journal-title":"Cancer research"},{"key":"13","doi-asserted-by":"crossref","first-page":"380","DOI":"10.1002\/path.3000","article-title":"Anoikis: an emerging hallmark in health and diseases","volume":"226","author":"Chiarugi","year":"2012","journal-title":"The Journal of pathology"},{"key":"14","doi-asserted-by":"crossref","first-page":"2865","DOI":"10.4161\/cc.10.17.17188","article-title":"Tracking the intermediate stages of epithelial-mesenchymal transition in epithelial stem cells and cancer","volume":"10","author":"Abell","year":"2011","journal-title":"Cell cycle"},{"key":"15","doi-asserted-by":"crossref","first-page":"1279","DOI":"10.15252\/emmm.201404208","article-title":"Epithelial-mesenchymal transition spectrum quantification and its efficacy in deciphering survival and drug responses of cancer patients","volume":"6","author":"Thiery","year":"2014","journal-title":"EMBO molecular medicine"},{"key":"16","doi-asserted-by":"crossref","first-page":"1899","DOI":"10.1038\/onc.2014.136","article-title":"Epithelial-mesenchymal status renders differential responses to cisplatin in ovarian cancer","volume":"34","author":"Mori","year":"2015","journal-title":"Oncogene"},{"key":"17","doi-asserted-by":"crossref","first-page":"88","DOI":"10.1186\/1756-0500-6-88","article-title":"Peritoneal tuberculosis mimicking advanced ovarian carcinoma: an important differential diagnosis to consider","volume":"6","author":"Sylvester","year":"2013","journal-title":"BMC Res Notes"},{"key":"18","doi-asserted-by":"crossref","first-page":"58","DOI":"10.4103\/0971-3026.59757","article-title":"CT mimics of peritoneal carcinomatosis","volume":"20","author":"Rajagopal","year":"2010","journal-title":"The Indian journal of radiology & imaging"},{"key":"19","doi-asserted-by":"crossref","first-page":"1","DOI":"10.1016\/j.ijgo.2013.10.001","article-title":"Staging classification for cancer of the ovary, fallopian tube, and peritoneum","volume":"124","author":"Oncology","year":"2014","journal-title":"International journal of gynaecology and obstetrics: the official organ of the International Federation of Gynaecology and Obstetrics"},{"key":"20","doi-asserted-by":"crossref","first-page":"8057","DOI":"10.1038\/srep08057","article-title":"Correlation of circular RNA abundance with proliferation - exemplified with colorectal and ovarian cancer, idiopathic lung fibrosis, and normal human tissues","volume":"5","author":"Pils","year":"2015","journal-title":"Scientific reports"},{"key":"21","doi-asserted-by":"crossref","first-page":"163","DOI":"10.1016\/j.prp.2012.01.003","article-title":"Aberrant pattern of the cytokeratin 7\/cytokeratin 20 immunophenotype in colorectal adenocarcinomas with BRAF mutations","volume":"208","author":"Jung","year":"2012","journal-title":"Pathology, research and practice"},{"key":"22","doi-asserted-by":"crossref","first-page":"4850","DOI":"10.1073\/pnas.0709810105","article-title":"Netrin-1 expression confers a selective advantage for tumor cell survival in metastatic breast cancer","volume":"105","author":"Mehlen","year":"2008","journal-title":"Proceedings of the National Academy of Sciences of the United States of America"},{"key":"23","doi-asserted-by":"crossref","first-page":"1452","DOI":"10.1093\/carcin\/bgp137","article-title":"Overexpression of MUC15 activates extracellular signal-regulated kinase 1\/2 and promotes the oncogenic potential of human colon cancer cells","volume":"30","author":"Huang","year":"2009","journal-title":"Carcinogenesis"},{"key":"24","doi-asserted-by":"crossref","first-page":"e110064","DOI":"10.1371\/journal.pone.0110064","article-title":"CXCL17 expression predicts poor prognosis and correlates with adverse immune infiltration in hepatocellular carcinoma","volume":"9","author":"Lau","year":"2014","journal-title":"PloS one"},{"key":"25","doi-asserted-by":"crossref","first-page":"587","DOI":"10.1530\/ERC-13-0485","article-title":"VGLL1 expression is associated with a triple-negative basal-like phenotype in breast cancer","volume":"21","author":"Palacios","year":"2014","journal-title":"Endocrine-related cancer"},{"key":"26","doi-asserted-by":"crossref","first-page":"2347","DOI":"10.2174\/138161212800165979","article-title":"Interleukin-7: a key mediator in T cell-driven autoimmunity, inflammation, and tissue destruction","volume":"18","author":"van Roon","year":"2012","journal-title":"Current pharmaceutical design"},{"key":"27","doi-asserted-by":"crossref","first-page":"e6098","DOI":"10.1371\/journal.pone.0006098","article-title":"Deconvolution of blood microarray data identifies cellular activation patterns in systemic lupus erythematosus","volume":"4","author":"Clark","year":"2009","journal-title":"PloS one"},{"key":"28","doi-asserted-by":"crossref","first-page":"4311","DOI":"10.1158\/0008-5472.CAN-08-0364","article-title":"Identification and characterization of ovarian cancer-initiating cells from primary human tumors","volume":"68","author":"Nephew","year":"2008","journal-title":"Cancer research"},{"key":"29","first-page":"25","article-title":"Phenotypic mapping of human mesothelial cells","volume":"14","author":"Dobbie","year":"1998","journal-title":"Advances in peritoneal dialysis Conference on Peritoneal Dialysis"},{"key":"30","doi-asserted-by":"crossref","first-page":"29","DOI":"10.4103\/2277-9175.98155","article-title":"Proliferative index using Ki-67 index in reactive mesothelial versus metastatic adenocarcinoma cells in serous fluid","volume":"1","author":"Desfuli","year":"2012","journal-title":"Advanced biomedical research"},{"key":"31","doi-asserted-by":"crossref","first-page":"3260","DOI":"10.1158\/0008-5472.CAN-11-4141","article-title":"Oncogenic PI3K mutations lead to NF-kappaB-dependent cytokine expression following growth factor deprivation","volume":"72","author":"Baldwin","year":"2012","journal-title":"Cancer research"},{"key":"32","doi-asserted-by":"crossref","first-page":"4112","DOI":"10.1158\/0008-5472.CAN-12-3801","article-title":"Cancer stem-like cell marker CD44 promotes bone metastases by enhancing tumorigenicity, cell motility, and hyaluronan production","volume":"73","author":"Nakamura","year":"2013","journal-title":"Cancer research"},{"key":"33","doi-asserted-by":"crossref","first-page":"145","DOI":"10.1002\/stem.1556","article-title":"CD44 expressed on cancer-associated fibroblasts is a functional molecule supporting the stemness and drug resistance of malignant cancer cells in the tumor microenvironment","volume":"32","author":"Takakura","year":"2014","journal-title":"Stem cells"},{"key":"34","doi-asserted-by":"crossref","first-page":"1537","DOI":"10.1007\/s00404-012-2456-6","article-title":"Matrix metalloproteinase-9 expression correlates with prognosis and involved in ovarian cancer cell invasion","volume":"286","author":"Li","year":"2012","journal-title":"Archives of gynecology and obstetrics"},{"key":"35","doi-asserted-by":"crossref","first-page":"681","DOI":"10.1083\/jcb.201208162","article-title":"Keratins control intercellular adhesion involving PKC-alpha-mediated desmoplakin phosphorylation","volume":"201","author":"Magin","year":"2013","journal-title":"The Journal of cell biology"},{"key":"36","doi-asserted-by":"crossref","first-page":"e46858","DOI":"10.1371\/journal.pone.0046858","article-title":"Isolation and characterization of tumor cells from the ascites of ovarian cancer patients: molecular phenotype of chemoresistant ovarian tumors","volume":"7","author":"Ahmed","year":"2012","journal-title":"PloS one"},{"key":"37","doi-asserted-by":"crossref","first-page":"1399","DOI":"10.2165\/11209040-000000000-00000","article-title":"Catumaxomab: in malignant ascites","volume":"72","author":"Frampton","year":"2012","journal-title":"Drugs"},{"key":"38","article-title":"A survey of treatment approaches of malignant ascites in Germany and Austria","author":"Luftner","year":"2014","journal-title":"Supportive care in cancer : official journal of the Multinational Association of Supportive Care in Cancer"},{"key":"39","first-page":"1281","article-title":"Spectrum of p53 mutations in biopsies from breast cancer patients selected for preoperative chemotherapy analysed by the functional yeast assay to predict therapeutic response","volume":"11","author":"Zeillinger","year":"2004","journal-title":"Oncology reports"},{"key":"40","volume-title":"R: A Language and Environment for Statistical Computing","author":"R Core Team","year":"2012"}],"container-title":["Oncotarget"],"original-title":[],"language":"en","link":[{"URL":"https:\/\/www.oncotarget.com\/lookup\/doi\/10.18632\/oncotarget.3746","content-type":"unspecified","content-version":"vor","intended-application":"similarity-checking"}],"deposited":{"date-parts":[[2020,5,13]],"date-time":"2020-05-13T12:27:10Z","timestamp":1589372830000},"score":1,"resource":{"primary":{"URL":"https:\/\/www.oncotarget.com\/lookup\/doi\/10.18632\/oncotarget.3746"}},"subtitle":[],"short-title":[],"issued":{"date-parts":[[2015,5,11]]},"references-count":40,"journal-issue":{"issue":"19","published-print":{"date-parts":[[2015,7,10]]}},"alternative-id":["3746","25991672"],"URL":"https:\/\/doi.org\/10.18632\/oncotarget.3746","relation":{},"ISSN":["1949-2553"],"issn-type":[{"value":"1949-2553","type":"electronic"}],"subject":[],"published":{"date-parts":[[2015,5,11]]}}}